L. V. Vorotilina

The efficacy of the combination of eribulin and trastuzumab in advanced HER2-positive breast cancer: the results of Russian observational study

N. O. Popova, O. S. Frolova, E. Kovalenko, 2020, Journal of Modern Oncology.

Efficacy and safety of eribulin in HER2-negative metastatic breast cancer: the results of long-term experience in real clinical practice in Russia

L. Bolotina, V. Gorbunova, E. Ovchinnikova, 2019, Journal of Modern Oncology.